|
ORC3L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.364820E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.389600E-01 |
| Normal-vs-Stage2 |
1.317630E-01 |
| Normal-vs-Stage3 |
5.591400E-01 |
| Normal-vs-Stage4 |
1.182160E-01 |
| Stage1-vs-Stage2 |
2.533000E-01 |
| Stage1-vs-Stage3 |
8.085600E-01 |
| Stage1-vs-Stage4 |
3.677800E-01 |
| Stage2-vs-Stage3 |
2.240400E-01 |
| Stage2-vs-Stage4 |
5.350000E-01 |
| Stage3-vs-Stage4 |
3.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.277580E-01 |
| Normal-vs-AfricanAmerican |
3.593800E-01 |
| Normal-vs-Asian |
6.267000E-01 |
| Caucasian-vs-AfricanAmerican |
9.979600E-01 |
| Caucasian-vs-Asian |
5.202000E-01 |
| AfricanAmerican-vs-Asian |
4.838600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.006800E-01 |
| Normal-vs-Female |
1.639640E-01 |
| Male-vs-Female |
8.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.503800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.412200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.854040E-01 |
| Normal-vs-Age(81-100Yrs) |
9.575200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.272800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.828200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.372000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.335400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.281200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.670600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.028300E-02 |
| Normal-vs-Grade 2 |
2.251500E-02 |
| Normal-vs-Grade 3 |
3.257800E-01 |
| Normal-vs-Grade 4 |
3.420600E-01 |
| Grade 1-vs-Grade 2 |
6.741000E-01 |
| Grade 1-vs-Grade 3 |
3.568200E-01 |
| Grade 1-vs-Grade 4 |
8.003900E-02 |
| Grade 2-vs-Grade 3 |
1.459370E-01 |
| Grade 2-vs-Grade 4 |
5.741700E-03 |
| Grade 3-vs-Grade 4 |
8.497600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.833600E-04 |
| Normal-vs-ccB subtype |
4.631500E-02 |
| ccA subtype-vs-ccB subtype |
2.45729999681643E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.936200E-02 |
| Normal-vs-N1 |
2.417200E-01 |
| N0-vs-N1 |
1.515790E-01 |
|
|
